Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05765851 · ClinicalTrials.gov registry record · Phase 1

A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors

A Phase 1 study of Breast Cancer and Advanced Solid Tumor, sponsored by Daiichi Sankyo.

Active
Registry status
Phase 1
Development phase
78
Enrollment target
8
Study locations

NCT05765851 is a Phase 1 study of Breast Cancer and Advanced Solid Tumor that is active but no longer recruiting, run by Daiichi Sankyo. The registered enrollment target is 78 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05765851, a Phase 1 study of Breast Cancer and Advanced Solid Tumor, is active but no longer recruiting, sponsored by Daiichi Sankyo.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
78 participants
Enrollment target
8
Study locations

Study Summary

This study will evaluate the safety and efficacy of DS-1103a combination therapy in patients with advanced solid tumors.

Conditions Studied

Breast Cancer Advanced Solid Tumor

Interventions

  • DRUG T-DXd
  • DRUG DS-1103a

Study Locations (8)

Other

  • Princess Margaret Cancer Centre, University Health Network - Toronto
  • Hospital Universitari Vall d'Hebron - Barcelona

Florida

  • Florida Cancer Specialists - Sarasota

Rhode Island

  • Lifespan Cancer Institute - Providence

Utah

  • University of Utah - Salt Lake City

Virginia

  • NEXT Oncology - Fairfax

Haute Garonne

  • Oncopole - Institut Claudius Regaud - Toulouse

Rhone

  • Centre Léon Bérard - Lyon

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2023-05-30
Est. Completion 2026-06-30
Phase Phase 1

Sponsor

Daiichi Sankyo

236 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05765851

The ClinicalTrials.gov registry entry for NCT05765851 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which T-DXd is the first listed.

NCT05765851 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Other, Florida, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT05765851 about?

NCT05765851 is a clinical study titled "A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors". This study will evaluate the safety and efficacy of DS-1103a combination therapy in patients with advanced solid tumors.

What is the current status of trial NCT05765851?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 78 participants. The study started on 2023-05-30. Estimated completion is 2026-06-30.

What conditions does trial NCT05765851 study?

This clinical trial studies the following conditions: Breast Cancer, Advanced Solid Tumor.

What interventions are being tested in trial NCT05765851?

The interventions under investigation include: T-DXd (DRUG), DS-1103a (DRUG).

Who is sponsoring clinical trial NCT05765851?

This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05765851 being conducted?

This trial has 8 study locations across Florida, Rhode Island, Utah, Virginia, Haute Garonne. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Advanced Solid Tumor

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.